trending

Here’s why Telix’s (ASX: TLX) shares are up on ASX?

Mar 29, 2022

Key Takeaways:

  • Telix has been given FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment.
  • Telix has signed an exclusive deal with Xiel for the distribution of Illuccix® in the UK, Northern Ireland, and the Republic of Ireland.
  • Telix is forming a network of leading distribution partners to ensure a solid presence to improve its service to customer sites and bring its imaging agent to patients across the region.

On 29 March 2022, Telix Pharmaceuticals Limited (ASX: TLX) made two announcements. Post their release of announcements on ASX, the Company's shares moved up by 7.469% and were trading at AU$4.460 (AEDT 1:10 PM). In this article, we will look at these two announcements.

On 29 March 2022, Telix Pharmaceuticals Limited (ASX: TLX) made two announcements. Post their release of announcements on ASX, the Company's shares moved up by 7.469% and were trading at AU$4.460 (AEDT 1:10 PM). In this article, we will look at these two announcements.

By submitting your details and clicking on the button above, you agree to our Terms and Conditions, Privacy Policy and consent to receive marketing offers including to be contacted by email or phone. Before continuing, please read the Financial Services Guide available here.

Recent News

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions

Allow cookies